Back to dashboard
All PlansCoverageMedium impact

Newsletter Vol. 14, No. 51

New Jersey Medicaid·NJ · Nephrology, Oncology, Hematology·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This is a provider notice regarding Epoetin Alfa (Erythropoietin; EPO) policy changes. Without access to the full policy content, billing teams should review the complete newsletter for specific changes to coverage, billing requirements, or prior authorization rules for EPO treatments.

Action Required

Action needed
Immediately: Download and review Newsletter Vol. 14, No. 51 from the provided URL to understand specific changes to Epoetin Alfa billing requirements. Update billing procedures, prior authorization protocols, and staff training as specified in the complete policy document.

Related policy hubs